Cell Biotech Stock Forecast for 2023 - 2025 - 2030

Cell Biotech Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Cell Biotech's Revenue has grown by 10.85%, from ₩45.58B to ₩50.53B. For the following year, the 0 analysts predict that Cell Biotech's Revenue will drop by 5.74%, reaching ₩47.63B. In 2030, the professionals' prediction is that A049960's Revenue will decrease by 5.59%, reaching ₩47.70B.

Cell Biotech Dividend per Share Forecast for 2023 - 2025 - 2030

Cell Biotech's Dividend per Share has decreased by 0.00% In the last two years, from ₩450.00 to ₩450.00. In the following year, the 0 analysts surveyed believe that Cell Biotech's Dividend per Share will decrease by 0.00%, reaching ₩450.00. According to professionals, by 2030, Cell Biotech's Dividend per Share will have decreased by 0.00%, falling down to ₩450.00.

Cell Biotech Free Cash Flow Forecast for 2023 - 2025 - 2030

Cell Biotech EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Cell Biotech's EBITDA has grown by 31.79%, rising from ₩7.35B to ₩9.69B. According to the 0 analysts polled, in the next year, Cell Biotech's EBITDA will fall by 1.81%, reaching ₩9.51B. By 2030, professionals believe that Cell Biotech's EBITDA will have decreased by 1.62%, falling to ₩9.53B.

Cell Biotech EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Cell Biotech's EBIT has grown, rising from ₩3.67B to ₩6.05B – a growth of 65.02%. For the next year, 0 analysts project Cell Biotech's EBIT to drop by 3.21%, reaching ₩5.86B. By 2030, professionals believe that Cell Biotech's EBIT will decrease by 2.94%, reaching ₩5.87B – a concerning trend for the company.

Cell Biotech EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Cell Biotech's EPS has decreased from ₩2583.00 to ₩0.00 – a 100.00% drop. For the next year, analysts are expecting EPS to reach ₩0.00 – an increase of 100.00%. Over the next six years, experts predict that EPS will grow by 100.00%.